Disease-specific alterations in IFN signalling have been previously identified in patients with COVID19 [20], and our recent publication on a similar patient cohort identified significantly increased levels of IFNs in the plasma of COVID19 + ICU patients compared to both age- and sex-matched COVID19− ICU patients and healthy controls [5]. Here, IFNA1 is linked to COVID-19.